JPMorgan Upgrades RXO, Inc. (RXO) to Neutral

October 6, 2026 2:34 AM

JPMorgan analyst Brian Ossenbeck upgraded RXO, Inc. (NYSE: RXO) from Underweight to Neutral with a price target of $30.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found